BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-04-29 |
|---|---|---|---|---|
| 2025 | $67.55 | $62.17 | $78.88 | 6.18% |
| 2026 | $86.07 | $69.44 | $96.43 | 35.28% |
| 2027 | $61.34 | $59.64 | $66.57 | -3.58% |
| 2028 | $57.16 | $52.73 | $60.1 | -10.15% |
| 2029 | $43.08 | $37.25 | $51.15 | -32.29% |
| 2030 | $31.64 | $27.19 | $36.4 | -50.26% |
| 2031 | $22.87 | $19.09 | $26.5 | -64.05% |
| 2032 | $15.68 | $14.07 | $18.36 | -75.35% |
| 2033 | $12.93 | $12.14 | $13.89 | -79.67% |
| 2034 | $11.79 | $11.64 | $12.05 | -81.48% |
| 2035 | $11.63 | $11.63 | $11.64 | -81.72% |
The 18 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$92.61 with a high forecast of $126.0 and a low forecast of $65.0.
The average BioMarin Pharmaceutical stock forecast represents a 45.57%
increase from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast for 2025, 8 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $67.55, a high forecast of $78.88, and a low forecast of $62.17.
The average BioMarin Pharmaceutical stock forecast 2025 represents a 6.18%
increase from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $86.07, a high forecast of $96.43, and a low forecast of $69.44.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 35.28%
increase from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast for 2028, 12 predictions are offered for each month of 2028 with average BioMarin Pharmaceutical stock
forecast of $57.16, a high forecast of $60.1, and a low forecast of $52.73.
The average BioMarin Pharmaceutical stock forecast 2028 represents a -10.15%
decrease from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $31.64, a high forecast of $36.4, and a low forecast of $27.19.
The average BioMarin Pharmaceutical stock forecast 2030 represents a -50.26%
decrease from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast 2031, 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $22.87, a high forecast of $26.5, and a low forecast of $19.09.
The average BioMarin Pharmaceutical stock forecast 2031 represents a -64.05%
decrease from the last price of $63.619998931884766.
For BioMarin Pharmaceutical stock forecast for 2035 (10 year), 4 predictions are offered for each month of 2035 with average BioMarin Pharmaceutical stock
forecast of $11.63, a high forecast of $11.64, and a low forecast of $11.63.
The average BioMarin Pharmaceutical stock forecast 2035 represents a -81.72%
decrease from the last price of $63.619998931884766.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $92.61, and this show a -2.77% decrease in average from the prior price target of the each prediction. Also, this average forecast of $92.61 represents a -8.02% decrease from the past average forecast of $100.69, 6 months ago from 32 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-02-24 | Oppenheimer | $98.0000 | Outperform | |
| 2025-02-20 | B of A Securities | $99.0000 | $103 | Buy |
| 2025-02-20 | Piper Sandler | $122.00 | $126 | Overweight |
| 2025-02-20 | UBS | $109.0000 | $113.0000 | Buy |
| 2025-02-20 | Cantor Fitzgerald | $90.0000 | $90.0000 | Overweight |
| 2025-02-20 | RBC Capital | $70 | $70.0000 | Sector Perform |
| 2025-02-20 | Citigroup | $81.00 | $82.0000 | Neutral |
| 2025-02-20 | Scotiabank | $78.00 | $80.0000 | Sector Perform |
| 2024-12-12 | Cantor Fitzgerald | $90.00 | $90.0000 | Overweight |
| 2024-11-15 | Wolfe Research | $95.0000 | Outperform | |
| 2024-10-30 | UBS | $104.0000 | $106.0000 | Buy |
| 2024-10-30 | Citigroup | $93.0000 | $81.0000 | Neutral |
| 2024-10-30 | Canaccord Genuity | $93.00 | $84.0000 | Hold |
| 2024-10-30 | Cantor Fitzgerald | $110.00 | $90 | Overweight |
| 2024-10-30 | JP Morgan | $110.0000 | $109.0000 | Overweight |
| 2024-10-30 | RBC Capital | $80.00 | $80.00 | Sector Perform |
| 2024-10-30 | Evercore ISI Group | $115.00 | $105 | Outperform |
| 2024-10-30 | Baird | $72.00 | $65 | Neutral |
| 2024-10-30 | William Blair | Market Perform | ||
| 2024-10-10 | Raymond James | $79.0000 | Outperform | |
| 2024-10-04 | Barclays | $110.00 | $86.0000 | Overweight |
| 2024-10-04 | RBC Capital | $85.00 | $80.0000 | Sector Perform |
| 2024-09-17 | RBC Capital | $100.00 | $85 | Sector Perform |
| 2024-09-17 | Bernstein | $116.0000 | $90.0000 | Outperform |
| 2024-09-17 | Stifel | $115.00 | $87 | Buy |
| 2024-09-17 | B of A Securities | $130 | $115 | Buy |
| 2024-09-17 | Wells Fargo | $115.0000 | $90.0000 | Overweight |
| 2024-09-17 | Truist Securities | $118.00 | $90 | Buy |
| 2024-09-17 | Scotiabank | $95.00 | $78.0000 | Sector Perform |
| 2024-09-13 | Canaccord Genuity | $93.0000 | $93 | Hold |
| 2024-09-09 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-09-05 | Piper Sandler | $107.00 | $122 | Overweight |
| 2024-09-05 | Truist Securities | $140.00 | $118 | Buy |
| 2024-09-05 | Scotiabank | $86.0000 | $95 | Sector Perform |
| 2024-09-05 | RBC Capital | $100.00 | $100.00 | Sector Perform |
| 2024-09-05 | JP Morgan | $111.0000 | $120.0000 | Overweight |
| 2024-08-27 | Piper Sandler | $107.00 | $107 | Overweight |
| 2024-08-21 | Stifel | $112.00 | $115 | Buy |
| 2024-08-20 | Bernstein | $94.0000 | $110.0000 | Outperform |
| 2024-08-06 | Evercore ISI Group | $113.0000 | $115 | Outperform |
| 2024-08-06 | Barclays | $111.00 | $110.0000 | Overweight |
| 2024-08-06 | RBC Capital | $100.0000 | $100 | Sector Perform |
| 2024-08-06 | Stifel | $108.0000 | $112 | Buy |
| 2024-08-06 | Scotiabank | $85.00 | $86.0000 | Sector Perform |
| 2024-08-06 | TD Cowen | $125.0000 | $120.0000 | Buy |
| 2024-08-05 | Cantor Fitzgerald | $110.00 | $110.00 | Overweight |
| 2024-07-25 | Canaccord Genuity | $89.00 | $89.0000 | Hold |
| 2024-07-22 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-06-27 | Wells Fargo | $110.00 | $115.0000 | Overweight |
| 2024-05-17 | Baird | $104.00 | $72 | Neutral |
| 2024-05-14 | Evercore ISI Group | $113 | Outperform |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-05-01 | $63.17 | -0.71% |
| 2025-05-02 | $64.40 | 1.95% |
| 2025-05-05 | $63.88 | -0.81% |
| 2025-05-06 | $64.03 | 0.24% |
| 2025-05-07 | $65.32 | 2.02% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 May. is $62.93 , for 2026 Apr. is $96.26 , for 2029 Apr. is $45.79 , for 2030 Apr. is $33.76 , for 2034 Apr. is $11.86 , and for 2035 Apr. is $11.64.
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 May. | $62.93 | -1.08% |
| 2025 Jun. | $62.17 | -1.20% |
| 2025 Jul. | $62.36 | 0.29% |
| 2025 Aug. | $63.78 | 2.28% |
| 2025 Sep. | $66.44 | 4.18% |
| 2025 Oct. | $69.81 | 5.06% |
| 2025 Nov. | $74.06 | 6.09% |
| 2025 Dec. | $78.88 | 6.51% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $83.36 | 5.68% |
| 2026 Feb. | $87.74 | 5.25% |
| 2026 Mar. | $92.64 | 5.58% |
| 2026 Apr. | $96.26 | 3.91% |
| 2026 May. | $96.43 | 0.18% |
| 2026 Jun. | $94.60 | -1.90% |
| 2026 Jul. | $91.37 | -3.42% |
| 2026 Aug. | $87.22 | -4.54% |
| 2026 Sep. | $82.58 | -5.32% |
| 2026 Oct. | $77.84 | -5.73% |
| 2026 Nov. | $73.32 | -5.81% |
| 2026 Dec. | $69.44 | -5.30% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $66.57 | -4.13% |
| 2027 Feb. | $64.40 | -3.26% |
| 2027 Mar. | $62.57 | -2.85% |
| 2027 Apr. | $61.01 | -2.49% |
| 2027 May. | $60.04 | -1.59% |
| 2027 Jun. | $59.91 | -0.21% |
| 2027 Jul. | $60.61 | 1.16% |
| 2027 Aug. | $60.92 | 0.51% |
| 2027 Sep. | $60.60 | -0.52% |
| 2027 Oct. | $59.64 | -1.59% |
| 2027 Nov. | $59.84 | 0.33% |
| 2027 Dec. | $60.00 | 0.28% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $60.10 | 0.16% |
| 2028 Feb. | $60.02 | -0.15% |
| 2028 Mar. | $59.70 | -0.53% |
| 2028 Apr. | $59.17 | -0.89% |
| 2028 May. | $58.48 | -1.17% |
| 2028 Jun. | $57.71 | -1.32% |
| 2028 Jul. | $57.01 | -1.22% |
| 2028 Aug. | $56.35 | -1.15% |
| 2028 Sep. | $55.64 | -1.26% |
| 2028 Oct. | $54.92 | -1.30% |
| 2028 Nov. | $54.09 | -1.51% |
| 2028 Dec. | $52.73 | -2.51% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $51.15 | -3.01% |
| 2029 Feb. | $49.40 | -3.41% |
| 2029 Mar. | $47.58 | -3.70% |
| 2029 Apr. | $45.79 | -3.76% |
| 2029 May. | $44.17 | -3.54% |
| 2029 Jun. | $42.77 | -3.15% |
| 2029 Jul. | $41.60 | -2.75% |
| 2029 Aug. | $40.59 | -2.41% |
| 2029 Sep. | $39.71 | -2.19% |
| 2029 Oct. | $38.88 | -2.09% |
| 2029 Nov. | $38.07 | -2.09% |
| 2029 Dec. | $37.25 | -2.15% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $36.40 | -2.26% |
| 2030 Feb. | $35.54 | -2.38% |
| 2030 Mar. | $34.65 | -2.49% |
| 2030 Apr. | $33.76 | -2.59% |
| 2030 May. | $32.86 | -2.66% |
| 2030 Jun. | $31.97 | -2.71% |
| 2030 Jul. | $31.10 | -2.72% |
| 2030 Aug. | $30.26 | -2.71% |
| 2030 Sep. | $29.44 | -2.69% |
| 2030 Oct. | $28.66 | -2.66% |
| 2030 Nov. | $27.91 | -2.62% |
| 2030 Dec. | $27.19 | -2.57% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $26.50 | -2.54% |
| 2031 Feb. | $25.83 | -2.53% |
| 2031 Mar. | $25.18 | -2.53% |
| 2031 Apr. | $24.53 | -2.55% |
| 2031 May. | $23.90 | -2.60% |
| 2031 Jun. | $23.26 | -2.67% |
| 2031 Jul. | $22.61 | -2.79% |
| 2031 Aug. | $21.94 | -2.94% |
| 2031 Sep. | $21.26 | -3.12% |
| 2031 Oct. | $20.55 | -3.32% |
| 2031 Nov. | $19.83 | -3.54% |
| 2031 Dec. | $19.09 | -3.72% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $18.36 | -3.84% |
| 2032 Feb. | $17.65 | -3.84% |
| 2032 Mar. | $17.00 | -3.72% |
| 2032 Apr. | $16.41 | -3.45% |
| 2032 May. | $15.91 | -3.07% |
| 2032 Jun. | $15.49 | -2.64% |
| 2032 Jul. | $15.14 | -2.21% |
| 2032 Aug. | $14.86 | -1.84% |
| 2032 Sep. | $14.63 | -1.56% |
| 2032 Oct. | $14.43 | -1.37% |
| 2032 Nov. | $14.25 | -1.28% |
| 2032 Dec. | $14.07 | -1.25% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $13.89 | -1.27% |
| 2033 Feb. | $13.71 | -1.32% |
| 2033 Mar. | $13.52 | -1.36% |
| 2033 Apr. | $13.33 | -1.40% |
| 2033 May. | $13.14 | -1.41% |
| 2033 Jun. | $12.96 | -1.39% |
| 2033 Jul. | $12.79 | -1.33% |
| 2033 Aug. | $12.63 | -1.25% |
| 2033 Sep. | $12.48 | -1.15% |
| 2033 Oct. | $12.35 | -1.04% |
| 2033 Nov. | $12.24 | -0.93% |
| 2033 Dec. | $12.14 | -0.82% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $12.05 | -0.71% |
| 2034 Feb. | $11.98 | -0.62% |
| 2034 Mar. | $11.91 | -0.54% |
| 2034 Apr. | $11.86 | -0.47% |
| 2034 May. | $11.81 | -0.41% |
| 2034 Jun. | $11.77 | -0.35% |
| 2034 Jul. | $11.73 | -0.30% |
| 2034 Aug. | $11.70 | -0.25% |
| 2034 Sep. | $11.68 | -0.20% |
| 2034 Oct. | $11.66 | -0.16% |
| 2034 Nov. | $11.65 | -0.12% |
| 2034 Dec. | $11.64 | -0.08% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $11.63 | -0.05% |
| 2035 Feb. | $11.63 | -0.01% |
| 2035 Mar. | $11.63 | 0.01% |
| 2035 Apr. | $11.64 | 0.04% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2025 May. is $62.93141858961926 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 Apr. is $96.26212386878785 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2029 Apr. is $45.78579839651891 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 Apr. is $33.75568891482932 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2034 Apr. is $11.855858842043379 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 Apr. is $11.635586389469227
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2026 Apr. is $96.26212386878785
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2025-04-29 is $63.619998931884766 and forecast for 2026 Apr. is $96.26, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2025-04-09 | $59.43 | $54.34 | $52.93 | $59.88 |
| BMRN stock price for 2025-04-10 | $56.32 | $57.57 | $54.79 | $58.33 |
| BMRN stock price for 2025-04-11 | $56.82 | $56.89 | $55.08 | $57.00 |
| BMRN stock price for 2025-04-14 | $59.67 | $58.19 | $57.39 | $59.99 |
| BMRN stock price for 2025-04-15 | $60.02 | $59.62 | $59.62 | $60.93 |
| BMRN stock price for 2025-04-16 | $58.82 | $59.66 | $58.36 | $60.46 |
| BMRN stock price for 2025-04-17 | $59.17 | $58.44 | $58.00 | $59.62 |
| BMRN stock price for 2025-04-21 | $58.65 | $58.49 | $58.29 | $59.91 |
| BMRN stock price for 2025-04-22 | $61.50 | $59.56 | $59.25 | $61.53 |
| BMRN stock price for 2025-04-23 | $61.94 | $62.16 | $61.63 | $63.39 |
| BMRN stock price for 2025-04-24 | $62.74 | $61.96 | $61.45 | $63.09 |
| BMRN stock price for 2025-04-25 | $63.30 | $62.64 | $61.56 | $63.44 |
| BMRN stock price for 2025-04-28 | $62.98 | $63.22 | $62.19 | $63.87 |
| BMRN stock price for 2025-04-29 | $63.62 | $62.97 | $62.33 | $64.07 |